There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

Giving older Americans access to weight-loss medicines through the US Medicare program would cost $35 billion over nine years ...

A growing number of employers are considering covering the blockbuster weight-loss drugs, several surveys show. Workers will ...

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...

A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...

That’s according to a new Employer Health Benefits Survey from KFF (formerly the Kaiser Family Foundation). But while a ...

Allowing Medicare to cover anti-obesity medications would drive up federal spending by about $35 billion on net between 2026 and 2034, according to ...

Authorizing Medicare to cover weight loss drugs would increase federal spending by about $35 billion from 2026 to 2034 ...

PS makes wellness more accessible through real-life stories, first-person perspectives, and expert-backed information. Our ...

More severe side effects can include pancreatitis, vision changes, allergic reactions, fatigue or dizziness, gallstones, ...